Essential thrombocytosis epidemiology and demographics
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis epidemiology and demographics |
|
FDA on Essential thrombocytosis epidemiology and demographics |
|
CDC on Essential thrombocytosis epidemiology and demographics |
|
Essential thrombocytosis epidemiology and demographics in the news |
|
Blogs on Essential thrombocytosis epidemiology and demographics |
|
Risk calculators and risk factors for Essential thrombocytosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology
Essential thrombocytosis is diagnosed at a rate of about 2 to 3 per 100,000 individuals annually.[1][2] The disease usually affects middle aged to elderly individuals, with an average age at diagnosis of 50-60 years, although it can affect children and young adults as well.[3]
References
- ↑ Mesa R, Silverstein M, Jacobsen S, Wollan P, Tefferi A (1999). "Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995". Am J Hematol. 61 (1): 10–5. PMID 10331505.
- ↑ Kutti J, Ridell B (2001). "Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis". Pathol Biol (Paris). 49 (2): 164–6. PMID 11317963.
- ↑ Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.